登录 注册 会员服务 联系我们

Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways

  • Published:2013-03-20 Issue:5 Volume:104 Page:604-610
  • ISSN:1347-9032
  • Container-title:Cancer Science
  • language:en
  • Short-container-title:Cancer Sci

Author:

Zhang Long,Ji Qing1,Liu Xuan1,Chen Xingzhu,Chen Zhaohua2,Qiu Yanyan1,Sun Jian1,Cai Jianfeng3,Zhu Huirong4,Li Qi

Affiliation:

1. Interventional Cancer Institute of Integrative Medicine & Putuo Hospital; Shanghai University of Traditional Chinese Medicine; Shanghai; China

2. Institute of Biomedical Sciences and School of Life Sciences; East China Normal University; Shanghai; China

3. Department of Chemistry; University of South Florida; Tampa; Florida; USA

4. Department of Medical Oncology; Shuguang Hospital; Shanghai University of Traditional Chinese Medicine; Shanghai; China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference28 articles.

1. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

2. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

3. Molecular origins of cancer;Burstein;N Engl J Med,2008

4. Tumor angiogenesis;Kerbel;N Engl J Med,2008

5. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation;Chen;Cancer Biol Ther,2008
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3